Viatris Inc.(VTRS)
đ Upcoming Dividend Payout
$0.12per Share
For shareholders of Viatris Inc., an upcoming dividend of $0.12 per share is scheduled to be paid on June 16, 2025.
Ex-Dividend Date:May 23, 2025
đ Dividend Highlights
Previous Payout History
16 payouts shown| Pay Date | Amount Per Share | Change vs Previous |
|---|---|---|
| March 18, 2025 | $0.12 | - |
| December 13, 2024 | $0.12 | - |
| September 13, 2024 | $0.12 | - |
| June 14, 2024 | $0.12 | - |
| March 18, 2024 | $0.12 | - |
| December 15, 2023 | $0.12 | - |
| September 15, 2023 | $0.12 | - |
| June 16, 2023 | $0.12 | - |
| March 17, 2023 | $0.12 | - |
| December 16, 2022 | $0.12 | - |
| September 16, 2022 | $0.12 | - |
| June 16, 2022 | $0.12 | - |
| March 16, 2022 | $0.12 | â˛9.09% |
| December 16, 2021 | $0.11 | - |
| September 16, 2021 | $0.11 | - |
| June 16, 2021 | $0.11 |
Overall Dividend Trend
Dividend per share has changed by+9.09%over the past 4years(comparing first and last payout shown).
About Viatris Inc.
Viatris Inc. is a global healthcare company established in November 2020 through the merger of Mylan N.V. and Upjohn, a division of Pfizer. Headquartered in Canonsburg, Pennsylvania, Viatris focuses on empowering people worldwide to live healthier at every stage of life. The company provides a broad portfolio of medications, including branded, generic, and over-the-counter products across a variety of therapeutic areas. Viatris is led by CEO Scott A. Smith, who brings extensive leadership experience in the pharmaceutical industry. In 2022, Viatris reported revenue of approximately $16.26 billion, showcasing its significant impact in the healthcare sector. With a mission of providing affordable and accessible medicines, Viatris operates in over 165 countries and territories, aiming to bridge the gap in global healthcare needs by enhancing access and sustainable operations.
Related Companies
Pfizer Inc.(PFE)Dividend data last updated:Tue, 20 May 2025 21:26:16 GMT. Financial data is indicative and provided for informational purposes only.